90556-87-9 Usage
Uses
Used in Pharmaceutical Synthesis:
3-Hydrazino-benzoic acid ethyl ester is used as a reagent in the pharmaceutical industry for the preparation of various pharmaceutical compounds. Its unique chemical structure allows it to be a key component in the synthesis of drugs with potential therapeutic applications.
Used in Dye and Pigment Production:
In the dye and pigment industry, 3-Hydrazino-benzoic acid ethyl ester is utilized in the production of dyes and pigments. Its chemical properties contribute to the color and stability of these products, making it an essential component in their manufacturing process.
Used in Material Development:
3-Hydrazino-benzoic acid ethyl ester is also used in the development of new materials. Its versatility as a building block allows for the creation of diverse chemical structures, which can be applied in various material science applications to enhance properties such as strength, durability, or conductivity.
Used in Scientific Research:
In the field of scientific research, 3-Hydrazino-benzoic acid ethyl ester serves as a valuable tool for the creation of new chemical structures. Researchers use 3-HYDRAZINO-BENZOIC ACID ETHYL ESTER to explore its potential applications and to gain a deeper understanding of its chemical properties and interactions with other compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 90556-87-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,5,5 and 6 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 90556-87:
(7*9)+(6*0)+(5*5)+(4*5)+(3*6)+(2*8)+(1*7)=149
149 % 10 = 9
So 90556-87-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H12N2O2/c1-2-13-9(12)7-4-3-5-8(6-7)11-10/h3-6,11H,2,10H2,1H3
90556-87-9Relevant academic research and scientific papers
SUBSTITUTED 2-AMINOPYRIDINE PROTEIN KINASE INHIBITOR
-
Paragraph 0259, (2015/12/19)
Disclosed are a 2-aminopyridine derivative having protein kinase inhibition activity, a preparation method and a pharmaceutical composition thereof Also disclosed are uses of the compounds and the pharmaceutical compositions thereof in the preparation of drugs for treating and/or preventing protein kinase-related diseases.
Discovery and optimization of 1,3,4-trisubstituted-pyrazolone derivatives as novel, potent, and nonsteroidal farnesoid X receptor (FXR) selective antagonists
Huang, Huang,Yu, Ying,Gao, Zhenting,Jin, Hui,Yan, Wenzhong,Ma, Ruoqun,Zhu, Jin,Shen, Xu,Jiang, Hualiang,Li, Jian,Li, Chenjing,Xu, Xing,Chen, Lili,Zhang, Yong
, p. 7037 - 7053,17 (2012/12/11)
LBVS of 12480 in-house compounds, followed by HTRF assay, resulted in one nonsteroidal compound (11) with antagonistic activity against FXR (69.01 ± 11.75 μM). On the basis of 11, 26 new derivatives (12a-z) were designed and synthesized accordingly. Five
Discovery and optimization of 1,3,4-trisubstituted-pyrazolone derivatives as novel, potent, and nonsteroidal farnesoid X receptor (FXR) selective antagonists
Huang, Huang,Yu, Ying,Gao, Zhenting,Zhang, Yong,Li, Chenjing,Xu, Xing,Jin, Hui,Yan, Wenzhong,Ma, Ruoqun,Zhu, Jin,Shen, Xu,Jiang, Hualiang,Chen, Lili,Li, Jian
, p. 7037 - 7053 (2013/01/14)
LBVS of 12480 in-house compounds, followed by HTRF assay, resulted in one nonsteroidal compound (11) with antagonistic activity against FXR (69.01 ± 11.75 μM). On the basis of 11, 26 new derivatives (12a-z) were designed and synthesized accordingly. Five
